Skip to Main content

Export Publications

Export the displayed publications:
Number of documents

63

Curriulum vitae Schvoerer Evelyne


Journal articles61 documents

  • H. Fenaux, M. Chassaing, S. Berger, C. Gantzer, I. Bertrand, et al.. Transmission of hepatitis E virus by water: An issue still pending in industrialized countries. Water Research, IWA Publishing, 2019, 151, pp.144-157. ⟨10.1016/j.watres.2018.12.014⟩. ⟨hal-02014228⟩
  • Morgan Faivre, Vanessa Cottet, Jean-Baptiste Bour, Carine Richou, Séverine Valmary-Degano, et al.. Impact of Cytomegalovirus Infection on the Outcome of Patients With Cirrhosis. Journal of Clinical Gastroenterology, Lippincott, Williams & Wilkins, In press, 53 (3), pp.236-241. ⟨10.1097/MCG.0000000000001039⟩. ⟨hal-01978375⟩
  • Maxime Grude, Marie-Josée Carles, Laurence Meyer, Catherine Roussel, H. Le Guillou-Guillemette, et al.. Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?. Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2019, 75 (1), pp.183-193. ⟨10.1093/jac/dkz404⟩. ⟨hal-02359382⟩
  • Cédric Hartard, Christophe Gantzer, Jean‐pierre Bronowicki, Evelyne Schvoerer. Emerging hepatitis E virus compared with hepatitis A virus: A new sanitary challenge. Reviews in Medical Virology, Wiley, 2019, 29 (6), pp.328-340. ⟨10.1002/rmv.2078⟩. ⟨hal-02921758⟩
  • E Raymond, F. Nicot, A Morand-Joubert, D Rodallec, M Mourez, et al.. Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen. Clinical Infectious Diseases, Oxford University Press (OUP), 2018, 66 (10), pp.1588 - 1594. ⟨10.1093/cid/cix1070⟩. ⟨hal-01899957⟩
  • H. Fenaux, M. Chassaing, S. Berger, H. Jeulin, A. Gentilhomme, et al.. Molecular features of Hepatitis E Virus circulation in environmental and human samples. Journal of Clinical Virology, Elsevier, 2018, 103, pp.63 - 70. ⟨10.1016/j.jcv.2018.04.003⟩. ⟨hal-01901546⟩
  • L Lambert-Niclot, C Grude, L. Chaix, L Charpentier, C Reigadas, et al.. Emerging resistance mutations in PI-naive patients failing an atazanavir-based regimen (ANRS multicentre observational study). Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2018, 73 (8), pp.2147 - 2151. ⟨10.1093/jac/dky142⟩. ⟨hal-01899927⟩
  • Marine Eschlimann, Brice Malve, Aurélie Velay, Honorine Fenaux, Sibel Berger, et al.. The variability of hepatitis B envelope is associated with HBs antigen persistence in either chronic or acute HBV genotype A infection. Journal of Clinical Virology, Elsevier, 2017, 94, pp.115 - 122. ⟨10.1016/j.jcv.2017.08.001⟩. ⟨hal-01903775⟩
  • Brice Malve, Marine Eschlimann, Shaunagh Galgey, Honorine Fenaux, Fabien Zoulim, et al.. Impact of deletions and mutations in Hepatitis B virus envelope proteins on serological profile and clinical evolution. Virus Research, Elsevier, 2017, 238 (3), pp.141-147. ⟨10.1016/j.virusres.2017.06.028⟩. ⟨hal-02014270⟩
  • Sophie Lafontaine, Christine Prin-Mathieu, Aurélie Velay, Odette Agulles, Evelyne Schvoerer, et al.. Evaluation of Virological Microparticle Enzyme Immunoassay According to the ISO 15189: Real-Life Experience in a University Hospital.. Clinical Laboratory, Clinical Laboratory Publications, 2016, 62 (3), pp.275-84. ⟨hal-02014290⟩
  • Abderrahim Oussalah, Patrice Hodonou Avogbe, Erwan Guyot, Céline Chery, Rosa-Maria Guéant, et al.. BRIP1 coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV- or HBV-related liver disease.. Oncotarget, Impact journals, 2016, 8 (38), pp.62842-62857. ⟨10.18632/oncotarget.11327⟩. ⟨hal-01494359⟩
  • A. Velay, H. Jeulin, M. Eschlimann, B. Malvé, F. Goehringer, et al.. Characterization of hepatitis B virus surface antigen variability and impact on HBs antigen clearance under nucleos(t)ide analogue therapy. Journal of Viral Hepatitis, Wiley-Blackwell, 2016, 23 (5), pp.387-398. ⟨10.1111/jvh.12498⟩. ⟨hal-01482132⟩
  • Alexandra Ducancelle, Adeline Pivert, Sandrine Bertrais, Jérôme Boursier, Viorica Balan, et al.. Different precore/core mutations of hepatitis B interact with, limit, or favor liver fibrosis severity. Journal of Gastroenterology and Hepatology, Wiley, 2016, 31 (10), pp.1750 - 1756. ⟨10.1111/jgh.13338⟩. ⟨hal-01482298⟩
  • Sylvie Larrat, Sophie Vallet, Sandra David-Tchouda, Alban Caporossi, Jennifer Margier, et al.. Naturally Occurring Resistance-Associated Variants of Hepatitis C Virus Protease Inhibitors in Poor Responders to Pegylated Interferon-Ribavirin. Journal of Clinical Microbiology, American Society for Microbiology, 2015, 53 (7), pp.2195-2202. ⟨10.1128/JCM.03633-14⟩. ⟨hal-02014295⟩
  • Cathia Soulié, Diane Descamps, Vé Ronique Schneider, Mary-Anne Trabaud, Laurence Morand-Joubert, et al.. Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma. Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2015, 70 (2), pp.566-572. ⟨10.1093/jac/dku419⟩. ⟨hal-02291062⟩
  • François Habersetzer, Rémy Moenne-Loccoz, Nicolas Meyer, Evelyne Schvoerer, Pauline Simo-Noumbissie, et al.. Loss of hepatitis B surface antigen in a real-life clinical cohort of patients with chronic hepatitis B virus infection. Liver International, Wiley-Blackwell, 2015, http://onlinelibrary.wiley.com/doi/10.1111/liv.12661/abstract;jsessionid=47085F0CA5A8A04F28BEB3C0A9B07BE5.f03t04?systemMessage=Wiley+Online+Library+will+be+unavailable+on+Saturday+25th+March+from+07%3A00+GMT+%2F+03%3A00+EDT+%2F+15%3A00+SGT+for+4+hours+for+essential+maintenance.++Apologies+for+the+inconvenience., 35 (1), pp.130 - 139. ⟨10.1111/liv.12661⟩. ⟨hal-01488141⟩
  • Pierre Frange, Pierre Assoumou, Diane Descamps, Antoine Chéret, Cécile Goujard, et al.. HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007–12: impact on susceptibility to first-line strategies. Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2015, 70 (7), pp.2084-2089. ⟨10.1093/jac/dkv049⟩. ⟨hal-01983697⟩
  • H. Jeulin, M. Foissac, L. Boyer, N. Agrinier, Pascale Perrier, et al.. Real-life rilpivirine resistance and potential emergence of an E138A-positive HIV strain in north-eastern France. Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2014, 69 (11), pp.3095-3102. ⟨10.1093/jac/dku256⟩. ⟨hal-01484261⟩
  • Sophie Vallet, Sylvie Larrat, Syria Laperche, Hélène Le Guillou-Guillemette, Florence Legrand-Abravanel, et al.. Multicenter quality control of hepatitis C virus protease inhibitor resistance genotyping.. Journal of Clinical Microbiology, American Society for Microbiology, 2013, 51 (5), pp.1428-33. ⟨10.1128/JCM.03032-12⟩. ⟨hal-00935958⟩
  • Evelyne Schvoerer, Rémy Moenne-Loccoz, John Murray, Aurélie Velay, Marine Turek, et al.. Hepatitis C Virus Envelope Glycoprotein Signatures Are Associated With Treatment Failure and Modulation of Viral Entry and Neutralization. Journal of Infectious Diseases, Oxford University Press (OUP), 2013, 207 (8), pp.1306-1315. ⟨10.1093/infdis/jit032⟩. ⟨hal-02014345⟩
  • John Murray, Rémy Moenne-Loccoz, Aurélie Velay, François Habersetzer, Michel Doffoel, et al.. Genotype 1 hepatitis C virus envelope features that determine antiviral response assessed through optimal covariance networks. PLoS ONE, Public Library of Science, 2013, 8 (6), pp.e67254. ⟨10.1371/journal.pone.0067254⟩. ⟨hal-02014327⟩
  • Hélène Jeulin, Aurélie Velay, John Murray, Evelyne Schvoerer. Clinical impact of hepatitis B and C virus envelope glycoproteins. World Journal of Gastroenterology, Baishideng Publishing Group Co. Limited, 2013, 19 (5), pp.654-664. ⟨10.3748/wjg.v19.i5.654⟩. ⟨hal-01481003⟩
  • Diane Descamps, Lambert Assoumou, Marie-Laure Chaix, Antoine Chaillon, Sophie Pakianather, et al.. National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011. Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2013, 68 (11), pp.2626-2631. ⟨10.1093/jac/dkt238⟩. ⟨hal-02291004⟩
  • Cécile Henquell, Julien Guglielmini, Jannick Verbeeck, Antoine Mahul, Vincent Thibault, et al.. Evolutionary history of hepatitis C virus genotype 5a in France, a multicenter ANRS study. Infection, Genetics and Evolution, Elsevier, 2011, 11 (2), pp.496-503. ⟨10.1016/j.meegid.2010.12.015⟩. ⟨hal-02014356⟩
  • Syria Laperche, Françoise Bouchardeau, Vincent Thibault, Anne-Marie Roque-Afonso, Pascale Trimoulet, et al.. Interpretation of Real-Time PCR Results for Hepatitis C Virus RNA When Viral Load Is Below Quantification Limits. Journal of Clinical Microbiology, American Society for Microbiology, 2011, 49 (3), pp.1113-1115. ⟨10.1128/JCM.01511-10⟩. ⟨hal-02014377⟩
  • Sophie Vallet, Florent Viron, Cécile Henquell, Hélène Le Guillou-Guillemette, Gisèle Lagathu, et al.. NS3 protease polymorphism and natural resistance to protease inhibitors in French patients infected with HCV genotypes 1–5. Antiviral Therapy, International Medical Press, 2011, 16 (7), pp.1093-1102. ⟨10.3851/IMP1900⟩. ⟨hal-02014349⟩
  • R. Moenne-Loccoz, C. Razafinjatovo, F. Habersetzer, A. Ananna, M. Doffoel, et al.. Tropisme leucocytaire du virus de l’hépatite C – intérêt de l’analyse des séquences des gènes des glycoprotéines d’enveloppe virales E1 et E2. Pathologie Biologie, Elsevier Masson, 2010, 58 (2), pp.170-174. ⟨10.1016/j.patbio.2009.06.010⟩. ⟨hal-02014419⟩
  • N. Bouzgarrou, E. Hassen, S. Gabbouj, E. Schvoerer, N. Ben Mami, et al.. Lack of effect of tumor necrosis factor-alpha-308 G/A polymorphism on severity of liver fibrosis in Tunisian hepatitis C virus (HCV)-infected patients. Gastroentérologie Clinique et Biologique / Research and Clinics in Hepatology and Gastroenterology, Elsevier Masson, 2010, 34 (4-5), pp.297-304. ⟨10.1016/j.gcb.2010.03.008⟩. ⟨pasteur-01375285⟩
  • Florence Abravanel, Philippe Colson, Helene Le Guillou-Guillemette, Laurent Alric, Isabelle Ravaux, et al.. Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy.. Journal of Medical Virology, Wiley-Blackwell, 2009, 81 (12), pp.2029. ⟨10.1002/jmv.21583⟩. ⟨hal-00531821⟩
  • N. Bouzgarrou, E. Hassen, W. Mahfoudh, S. Gabbouj, E. Schvoerer, et al.. NS5A(ISDR-V3) Region Genetic Variability of Tunisian HCV-1b Strains: Correlation With the Response to the Combined Interferon/Ribavirin Therapy. Journal of Medical Virology, Wiley-Blackwell, 2009, 81 (12), pp.2021-2028. ⟨10.1002/jmv.21641⟩. ⟨pasteur-01375327⟩
  • Rebecca Pastor, François Habersetzer, Samira Fafi-Kremer, Michel Doffoel, Thomas-F Baumert, et al.. Hepatitis B virus mutations potentially conferring adefovir/tenofovir resistance in treatment-naive patients.. World Journal of Gastroenterology, Baishideng Publishing Group Co. Limited, 2009, 15 (6), pp.753-5. ⟨hal-02043721⟩
  • C Mello, C. Thumann, Evelyne Schvoerer, E. Soulier, P Pinho, et al.. Conservation of hepatitis C virus nonstructural protein 3 amino acid sequence in viral isolates during liver transplantation. Journal of Viral Hepatitis, Wiley-Blackwell, 2009, 16 (10), pp.732-737. ⟨10.1111/j.1365-2893.2009.01125.x⟩. ⟨hal-02014453⟩
  • F. Schramm, R. Moenne-Loccoz, S. Fafi-Kremer, E. Soulier, C. Royer, et al.. Étude du leucotropisme du virus de l’hépatite C par analyse des quasi-espèces virales dans le contexte de la transplantation hépatique. Pathologie Biologie, Elsevier Masson, 2008, 56 (7-8), pp.487-491. ⟨10.1016/j.patbio.2008.07.007⟩. ⟨hal-02014484⟩
  • C. Thumann, Evelyne Schvoerer, J.-D. Abraham, A. Bohbot, F. Stoll-Keller, et al.. Hepatitis C virus structural proteins do not prevent human dendritic cell maturation. Gastroentérologie Clinique et Biologique / Research and Clinics in Hepatology and Gastroenterology, Elsevier Masson, 2008, 32 (1), pp.59-68. ⟨10.1016/j.gcb.2007.12.006⟩. ⟨hal-02014496⟩
  • S. Fafi-Kremer, M.B. Zeisel, Evelyne Schvoerer, E. Soulier, F. Habersetzer, et al.. Anticorps neutralisants dirigés contre le virus de l’hépatite C. Gastroentérologie Clinique et Biologique / Research and Clinics in Hepatology and Gastroenterology, Elsevier Masson, 2008, 32 (5), pp.491-498. ⟨10.1016/j.gcb.2008.02.026⟩. ⟨hal-02014491⟩
  • Frédéric Schramm, Eric Soulier, Cathy Royer, Thierry Weitten, Samira Fafi‐kremer, et al.. Frequent Compartmentalization of Hepatitis C Virus with Leukocyte‐Related Amino Acids in the Setting of Liver Transplantation. Journal of Infectious Diseases, Oxford University Press (OUP), 2008, 198 (11), pp.1656-1666. ⟨10.1086/592986⟩. ⟨hal-02014476⟩
  • N. Bouzgarrou, E. Hassen, E. Schvoerer, F. Stoll-Keller, O. Bahri, et al.. Association of interleukin-18 polymorphisms and plasma level with the outcome of chronic HCV infection. Journal of Medical Virology, Wiley-Blackwell, 2008, 80 (4), pp.607 - 614. ⟨10.1002/jmv.21079⟩. ⟨pasteur-01375203⟩
  • Evelyne Schvoerer, Eric Soulier, Cathy Royer, Anne-Catherine Renaudin, Christine Thumann, et al.. Early Evolution of Hepatitis C Virus (HCV) Quasispecies after Liver Transplant for HCV‐Related Disease. Journal of Infectious Diseases, Oxford University Press (OUP), 2007, 196 (4), pp.528-536. ⟨10.1086/519691⟩. ⟨hal-02014515⟩
  • Mirjam Zeisel, George Koutsoudakis, Eva Schnober, Anita Haberstroh, Hubert Blum, et al.. Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81.. Hepatology, Wiley-Blackwell, 2007, 46 (6), pp.1722-31. ⟨10.1002/hep.21994⟩. ⟨inserm-00395706⟩
  • Evelyne Schvoerer, C. Thumann, E. Soulier, C. Royer, S. Fafi-Kremer, et al.. Récurrence de l'infection par le virus de l'hépatite C (VHC) après transplantation du foie pour hépatopathie due au VHC : facteurs liés à l'hôte et facteurs viraux impliqués dans la survenue et la gravité de la récurrence de l'hépatite virale C. Pathologie Biologie, Elsevier Masson, 2006, 54 (10), pp.556-560. ⟨10.1016/j.patbio.2006.07.027⟩. ⟨hal-02014523⟩
  • Pierre Zachary, Marie-Josée Wendling, Saadi Djeddi, Evelyne Schvoerer, Murielle Ullmann, et al.. Primary hepatitis C virus infection in an intravenous drug user: kinetics of virological markers.. Gastroentérologie Clinique et Biologique / Research and Clinics in Hepatology and Gastroenterology, Elsevier Masson, 2006, 30 (12), pp.1419-20. ⟨hal-02014519⟩
  • Evelyne Schvoerer, Valéry Frechin, S Fritsch, R Freitag, A. Fuchs, et al.. Atypical symptoms in patients with herpesvirus DNA detected by PCR in cerebrospinal fluid. Journal of Clinical Virology, Elsevier, 2006, 35 (4), pp.458-462. ⟨10.1016/j.jcv.2005.11.005⟩. ⟨hal-02014535⟩
  • Evelyne Schvoerer, Christine Thumann, Stephan Spohrer, Eric Soulier, Cathy Royer, et al.. Early decrease in circulating dendritic cells number after liver transplantation could favor hepatitis C virus recurrence. Journal of Medical Virology, Wiley-Blackwell, 2006, 78 (8), pp.1070-1075. ⟨10.1002/jmv.20664⟩. ⟨hal-02014530⟩
  • Pierre Zachary, Murielle Ullmann, Saadi Djeddi, Nicolas Meyer, Marie-Josée Wendling, et al.. Evaluation of three commercially available hepatitis C virus antibody detection assays under the conditions of a clinical virology laboratory. Journal of Clinical Virology, Elsevier, 2005, 34 (3), pp.207-210. ⟨10.1016/j.jcv.2005.06.005⟩. ⟨hal-02014543⟩
  • Evelyne Schvoerer, Sylvie Henriot, Pierre Zachary, Rachel Freitag, Anne Fuchs, et al.. Monitoring low cytomegalovirus viremia in transplanted patients by a real-time PCR on plasma. Journal of Medical Virology, Wiley-Blackwell, 2005, 76 (1), pp.76-81. ⟨10.1002/jmv.20326⟩. ⟨hal-02014550⟩
  • P. Zachary, M. Ullmann, Marie-Josée Wendling, S. Djeddi, Evelyne Schvoerer, et al.. Intérêt de l’immunoblot dans l’évaluation du statut sérologique vis-à-vis de l’hépatite C. Pathologie Biologie, Elsevier Masson, 2004, 52 (9), pp.517-521. ⟨10.1016/j.patbio.2004.07.024⟩. ⟨hal-02014552⟩
  • Evelyne Schvoerer, M.C. Navas, C. Thumann, A. Fuchs, N. Meyer, et al.. Production of interleukin-18 and interleukin-12 in patients suffering from chronic hepatitis C virus infection before antiviral therapy. Journal of Medical Virology, Wiley-Blackwell, 2003, 70 (4), pp.588-593. ⟨10.1002/jmv.10434⟩. ⟨hal-02014570⟩
  • Françoise Stoll-Keller, Evelyne Schvoerer, Christine Thumann, Maria-Cristina Navas, Anne-Marie Aubertin. Immunomodulating effect of HCV during the development of chronic hepatitis C: toward new therapeutic approaches. Bulletin de l'Académie Nationale de Médecine, Elsevier Masson, 2003, 187 (6), pp.1147-60; discussion 1160-1. ⟨hal-02014557⟩
  • Thomas Bourlet, Rachel Levy, Silvy Laporte, Stéphane Blachier, Laurence Bocket, et al.. Multicenter quality control for the detection of hepatitis C virus RNA in seminal plasma specimens.. Journal of Clinical Microbiology, American Society for Microbiology, 2003, 41 (2), pp.789-93. ⟨10.1128/JCM.41.2.789-793.2003⟩. ⟨hal-02014576⟩
  • Evelyne Schvoerer, Valéry Frechin, André Warter, Bernard Gasser, Hervé Jouin, et al.. Persistent multiple pulmonary nodules in a nonimmunocompromised woman after varicella-related myelitis treated with acyclovir.. Journal of Clinical Microbiology, American Society for Microbiology, 2003, 41 (10), pp.4904-5. ⟨10.1128/JCM.41.10.4904-4905.2003⟩. ⟨hal-02014563⟩
  • Elisabeth Legrand, Didier Neau, Tatiana Galpérine, Pascale Trimoulet, Jean-François Moreau, et al.. CD4 T Lymphocyte Proliferative Responses to Hepatitis C Virus (HCV) Antigens in Patients Coinfected with HCV and Human Immunodeficiency Virus Who Responded to Anti‐HCV Treatment. Journal of Infectious Diseases, Oxford University Press (OUP), 2002, 186 (3), pp.302-311. ⟨10.1086/341659⟩. ⟨hal-02014584⟩
  • Evelyne Schvoerer, Imed Kabissa, Emmanuelle Cotto, Anne-Christine Jouvencel, Charles Balabaud, et al.. Lamivudine therapy of chronic hepatitis B in three groups of patients: non transplanted patients, liver recipients, and kidney recipients.. Gastroentérologie Clinique et Biologique / Research and Clinics in Hepatology and Gastroenterology, Elsevier Masson, 2002, 26 (1), pp.62-6. ⟨hal-02014614⟩
  • Evelyne Schvoerer, F. Stoll-Keller. Utilisation des tests commercialisés pour le diagnostic d'une infection à CMV chez les greffés de moelle et d'organe. Annales de Biologie Clinique, John Libbey Eurotext, 2002, 60 (4), pp.463-7. ⟨hal-02043749⟩
  • P. Trimoulet, D. Neau, B. Le Bail, A. Rullier, M. Winnock, et al.. Intrahepatic HCV RNA loads in 37 HIV-HCV co-infected patients with controlled HIV infection. Journal of Medical Virology, Wiley-Blackwell, 2002, 67 (2), pp.143-151. ⟨10.1002/jmv.2203⟩. ⟨hal-02014607⟩
  • Maria-Cristina Navas, Anne Fuchs, Evelyne Schvoerer, Alain Bohbot, Anne-Marie Aubertin, et al.. Dendritic cell susceptibility to hepatitis C virus genotype 1 infection. Journal of Medical Virology, Wiley-Blackwell, 2002, 67 (2), pp.152-161. ⟨10.1002/jmv.2204⟩. ⟨hal-02014601⟩
  • Evelyne Schvoerer, M Ventura, O Dubos, G Cazaux, R Serceau, et al.. Qualitative and quantitative molecular detection of enteroviruses in water from bathing areas and from a sewage treatment plant.. Research in Microbiology, Elsevier, 2001, 152 (2), pp.179-86. ⟨10.1016/S0923-2508(01)01190-1⟩. ⟨hal-02014629⟩
  • Didier Neau, P. Trimoulet, M Winnock, B. Le Bail, Evelyne Schvoerer, et al.. Impact of protease inhibitors on intrahepatic hepatitis C virus viral load.. AIDS, Lippincott, Williams & Wilkins, 2001, 15 (13), pp.1736-8. ⟨hal-02014623⟩
  • Anne Caumont, Nguyen Thi Hoang Lan, Nguyen Thi Vy Uyen, Pham Van Hung, Evelyne Schvoerer, et al.. Sequence Analysis of env C2/V3, gag p17/p24, and pol Protease Regions of 25 HIV Type 1 Isolates from Ho Chi Minh City, Vietnam. AIDS Research and Human Retroviruses, Mary Ann Liebert, 2001, 17 (13), pp.1285-1291. ⟨10.1089/088922201750461357⟩. ⟨hal-02014617⟩
  • Evelyne Schvoerer, F. Bonnet, V. Dubois, G Cazaux, R Serceau, et al.. PCR detection of human enteric viruses in bathing areas, waste waters and human stools in Southwestern France.. Research in Microbiology, Elsevier, 2000, 151 (8), pp.693-701. ⟨10.1016/S0923-2508(00)90132-3⟩. ⟨hal-02014634⟩
  • D. Neau, Evelyne Schvoerer, D. Robert, F. Dubois, H. Dutronc, et al.. Hepatitis B Exacerbation with a Precore Mutant Virus Following Withdrawal of Lamivudine in a Human Immunodeficiency Virus-infected Patient. Journal of Infection, WB Saunders, 2000, 41 (2), pp.192-194. ⟨10.1053/jinf.2000.0724⟩. ⟨hal-02014644⟩
  • Evelyne Schvoerer, F. Bonnet, V. Dubois, M Rogues, J.-P. Gachie, et al.. A hospital outbreak of gastroenteritis possibly related to the contamination of tap water by a small round structured virus.. Journal of Hospital Infection, WB Saunders, 1999, 43 (2), pp.149-154. ⟨10.1053/jhin.1999.0632⟩. ⟨hal-02014649⟩

Conference papers1 document

  • Honorine Fenaux, Manon Chassaing, Sibel Berger, H. Jeulin, Mouni Bensenane, et al.. Hepatitis E virus emergence in north eastern France. 20th Annual Meeting of the European Society for Clinical Virology, 2017, Stresa, Italy. ⟨hal-02111074⟩

Poster communications1 document

  • M. Faivre, V. Cottet, Jb. Bour, C. Richou, S. Valmary-Degano, et al.. Impact of Cytomegalovirus infection on the outcome of patients with cirrhosis: a preliminary study . International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Apr 2017, Amsterdam, Netherlands. Journal of Hepatology 66 (1, supplement), pp.S559-S560, 2017, Abstracts of The International Liver Congress 2017 — 52nd Annual meeting of the European Association for the Study of the Liver. ⟨10.1016/S0168-8278(17)31534-9⟩. ⟨hal-01665366⟩